South African pharmaceutical group, Aspen, has agreed to sell its Asia Pacific operations to a private equity firm based in Melbourne, Australia, for approximately R26.5 billion.
The assets are sold following an unsolicited offer by BGH Capital, including Aspens operations in Australia, Hong Kong, Malaysia, Taiwan, the Philippines and excluding China.
The announcement made on Monday triggered Aspens biggest one-day share price gain in roughly 25 years with the stock jumping about 24 on the JSE.
